S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
NASDAQ:TLSA

Tiziana Life Sciences Stock Forecast, Price & News

$0.88
+0.05 (+6.03%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.85
$0.88
50-Day Range
$0.83
$1.44
52-Week Range
$0.78
$5.29
Volume
162,798 shs
Average Volume
138,725 shs
Market Capitalization
$85.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1
30 days | 90 days | 365 days | Advanced Chart
Receive TLSA News and Ratings via Email

Sign-up to receive the latest news and ratings for Tiziana Life Sciences and its competitors with MarketBeat's FREE daily newsletter.


Tiziana Life Sciences logo

About Tiziana Life Sciences

Tiziana Life Sciences Ltd. engages in the research and development of biotechnological and pharmaceutical products. It develops transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer related to the liver. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TLSA
Fax
N/A
Employees
11
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.64 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$85.60 million
Optionable
Not Optionable

Company Calendar

Today
1/19/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

0.85 out of 5 stars

Medical Sector

1318th out of 1,414 stocks

Pharmaceutical Preparations Industry

643rd out of 682 stocks

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Tiziana Life Sciences (NASDAQ:TLSA) Frequently Asked Questions

How has Tiziana Life Sciences' stock been impacted by COVID-19?

Tiziana Life Sciences' stock was trading at $3.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TLSA shares have decreased by 77.7% and is now trading at $0.8797.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Tiziana Life Sciences?

Tiziana Life Sciences saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 67,800 shares, a decrease of 64.0% from the December 15th total of 188,200 shares. Based on an average trading volume of 130,600 shares, the short-interest ratio is presently 0.5 days.
View Tiziana Life Sciences' Short Interest
.

Who are Tiziana Life Sciences' key executives?

Tiziana Life Sciences' management team includes the following people:
  • Kunwar Shailubhai, CEO, Executive Director & Chief Scientific Officer
  • Keeren Shah, Chief Financial Officer
  • Vaseem A. Palejwala, Director-Clinical Operations
  • Neil Graham, Chief Medical Officer
  • Thomas H. Adams, Executive Director & Head-Drug Development

What other stocks do shareholders of Tiziana Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tiziana Life Sciences investors own include Pfizer (PFE), Vaxart (VXRT), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Moderna (MRNA), Enterprise Products Partners (EPD), Novavax (NVAX), Dynavax Technologies (DVAX) and Gilead Sciences (GILD).

When did Tiziana Life Sciences IPO?

(TLSA) raised $10 million in an initial public offering on the week of November 19th 2018. The company issued 1,000,000 shares at $9.90 per share. Laidlaw & Company (UK) Ltd. acted as the underwriter for the IPO.

What is Tiziana Life Sciences' stock symbol?

Tiziana Life Sciences trades on the NASDAQ under the ticker symbol "TLSA."

How do I buy shares of Tiziana Life Sciences?

Shares of TLSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tiziana Life Sciences' stock price today?

One share of TLSA stock can currently be purchased for approximately $0.88.

How much money does Tiziana Life Sciences make?

Tiziana Life Sciences has a market capitalization of $85.60 million.

How many employees does Tiziana Life Sciences have?

Tiziana Life Sciences employs 11 workers across the globe.

What is Tiziana Life Sciences' official website?

The official website for Tiziana Life Sciences is www.tizianalifesciences.com.

Where are Tiziana Life Sciences' headquarters?

Tiziana Life Sciences is headquartered at 3RD FLOOR 11-12 ST. JAMES`S SQUARE, LONDON X0, SW1Y 4LB.

How can I contact Tiziana Life Sciences?

Tiziana Life Sciences' mailing address is 3RD FLOOR 11-12 ST. JAMES`S SQUARE, LONDON X0, SW1Y 4LB. The company can be reached via phone at 44-20-7495-2379 or via email at [email protected].


This page was last updated on 1/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.